Evaluation of the Frequency, Risk Factors, and Outcomes of ROP in Infants With a BW >1500 Grs or GA ≥33 Wks in Turkey.
The study includes preterm infants who are being screened for ROP between August 1,2023 and August 1, 2024 in 94 neonatal intensive care units (NICUs) in Turkey. Infants with birth weight (BW) of >1500 g or ≥ 33 weeks' gestation who are screened for retinopathy of prematurity are included. The incidence of any ROP, severe ROP and treatment modalities will be determined. The risk factors for ROP development will also be evaluated.
- EligibilityCriteria: Inclusion Criteria:  Infants with BW >1500 g or ≥33 weeks' gestation who were determined to be at risk for ROP by the attending clinician and were screened for ROP.  Exclusion Criteria:  Neonates who died before the first ROP examination are excluded from the study. - HealthyVolunteers: No - Gender: All - MinimumAge: 28 Days - StdAgeList: Child, Adult, Older Adult - StudyPopulation: Infants with BW >1500 g or ≥33 weeks' gestation who were screened for ROP. - SamplingMethod: Non-Probability Sample